The Central Commission for Discipline Inspection named the grass-roots president to eat kickbacks anti-corruption coverage expanded

Medical Network December 3rd, the Central Commission for Discipline Inspection named the grass-roots dean to eat kickbacks on December 1st, the Central Commission for Discipline Inspection issued the "case as a mirror." The article "The former good dean became a prisoner of the order" named the problem of the director of the primary medical institution receiving rebates for supplies.
article pointed out that after receiving the report, the local disciplinary committee set up an investigation team to organize the strength of Liu in recent years to serve in the health hospital accounts for all review.
in the course of the investigation, a drug supplies seller named Meng Ajun surfaced.
investigators found, "In general, the town health hospital used infusions are about 1 yuan a price, and Huangxuan Town Health Hospital infusions into the price is 5 yuan a? "After related verification, the investigation team found that Meng had transferred a fixed amount of money to a private account on time since 2014, just two days after the payment was made to him by Huangxuan Town Health Hospital.
bank verification, confirmed that the private account is Liu's wife's account.
According to the period of lien Liu's own account and other aspects of investigation and verification confirmed: from 2013 to 2016, Liu was the president of Huangxuan Town Health Hospital, illegally received medical supplies salesman Meng a military "kickback" a total of 1588 million yuan;
January 2019, Liu was expelled from the Party and dismissed from public office, and on June 28, 2019, the People's Court of Xiangshui County sentenced Liu to two years' imprisonment and a fine of 200,000 yuan for bribery and embezzlement.
in response to the problems reflected in the case, the relevant leaders of the local disciplinary committee said that efforts will be made to strengthen the supervision of the health system, especially in the procurement of drugs, large-scale medical equipment, medical supplies and public health and other key areas of special governance.
Medical corruption, kickbacks high in addition to the above-mentioned cases, Saibai Blue based on public information combing found that since 2020, up to the top three hospital director down to the leadership of the primary health hospital, there have been a number of hospital presidents, department heads were investigated, the main reasons they were investigated include receiving drugs, medical supplies rebates or the use of authority to interfere with infrastructure projects.
For example, according to The Anhui Discipline Inspection and Supervision Network on November 30, the former deputy secretary of the Party Committee and president of the First People's Hospital of Anqing City, a large third-tier A hospital, was expelled from the Party and public office for serious disciplinary violations.
After investigation, Gao a certain violation of the spirit and integrity of the central eight provisions of discipline, violation of gifts, gifts, violations of organizational discipline, in the selection and appointment of cadres to help others and accept bribes, violation of life discipline, suspected of bribery crimes.
According to the official website of the Heilongjiang Provincial Commission for Discipline Inspection on November 27, the former president of Harbin City First Hospital, Meng, is currently under disciplinary review and supervision investigation for suspected serious disciplinary violations.
according to public information, Meng joined the work in 1987, served as a deputy bureau-level cadre of Harbin Municipal Health and Health Commission in 2019, and retired early in December 2019.
The expansion of medical anti-corruption coverage for the heads of medical institutions at all levels was investigated and dealt with, as early as August 4, the Central Commission for Discipline Inspection, the State Supervision Commission website published an article pointed out that the local Commission for Discipline Inspection issued by the review of investigation information and party discipline and administrative sanctions information shows that - this year, medical anti-corruption coverage has been further expanded, from major public hospitals, to clinical trial institutions, medical research institutes, to township hospitals, community health service centers, relevant staff are included in the scope of strict inspection.
article combed found that in the first half of this year disclosed in the medical field corruption cases, the collection of drug supplies rebates is the most frequent problem, the amount involved in the case remains high, the chain of corrupt interests is chained together.
According to the "Notice on the Issuance of the Special Action Plan for the Construction of style in the medical industry in 2020" issued by the General Office of the National Health and Health Commission on July 24, from July this year until the end of the year, the focus will be on the treatment of medical personnel to collect kickbacks, drug companies illegal marketing and other acts.
scope of centralized treatment will achieve full coverage of hospitals (including Chinese hospitals and maternal and child health care hospitals) in the jurisdiction, and more than 50% coverage of other types of medical institutions (community health service centers (stations), outpatient clinics and clinics).
The Central Commission for Discipline Inspection also requires that discipline inspection and supervision organs at all levels, based on their functional responsibilities, keep a close eye on the risk points and high-risk links of integrity in the medical field, seriously investigate and punish leading cadres and public officials of Party members who violate discipline and law, and resolutely cut off the chain of corrupt interests.
investigation and prosecution of cases and institutional governance in an earlier article commented that the investigation and prosecution of cases played a warning, deterrent role, heavy-handed crackdown on disciplinary violations in the medical field can not be loose, can not be soft.
, we should also work the system and governance, strengthen the restriction and supervision of the operation of power, and promote the multi-pronged construction of comprehensive governance system.
At present, the national medical and health industry is carrying out special actions in the construction of style, focusing on punishing improper acts such as using their positions to facilitate the receipt of red envelopes, cracking down on illegal and illegal acts of receiving kickbacks, and seriously investigating and punishing illegal marketing practices of pharmaceutical products in medical institutions.
On June 5, this year, the National Health and Safety Commission, the Ministry of Public Security and other nine departments issued the "2020 correction of the field of pharmaceutical purchase and sale and medical services in the field of the wrong wind work points" stressed that serious investigation and punishment of the collection of pharmaceutical supplies enterprise rebate behavior - before the end of the year, led by the State Health Care Commission, the State Administration of Traditional Chinese Medicine, the State Health Insurance Bureau in accordance with their responsibilities, the State Administration of Market Supervision, the Ministry of Public Security in accordance with their duties, serious investigation and punishment of the collection of pharmaceutical supplies enterprise rebate behavior.
With gold, rebate space constantly compressed in addition to the phased clean-up, strict case, the Medical Insurance Bureau set up a medical recruitment credit evaluation system, the State Drug Administration issued a pharmaceutical representative filing system, the state organization of drugs, supplies centralized belt procurement, health insurance payment method reform, public hospital compensation system reform and other measures are aimed at reducing the sales space of gold from the system, rooting out the problem of pharmaceutical rebates.
, the State Health Insurance Administration issued "guidance on the establishment of a medical price and credit evaluation system", clearly involving pharmaceutical commercial bribery and other 7 kinds of disrelieving behavior of pharmaceutical enterprises will be included in the "black list" of disrelieving.
Some analysts pointed out that pharmaceutical companies need to act on behalf of the commercial bribery of enterprises to bear the price and recruitment of credit disciplinary responsibility, which means that once the drug companies in violation of the law, the cost of illegality will rise significantly, which is very different from the past drug companies easy to bring gold sales and other illegal issues dumped pot channel companies or pharmaceutical representatives and cut their own responsibilities.
The filing system for pharmaceutical representatives, which officially landed on December 1st, is also intended to bind the pharmaceutical representative's in-house promotion behavior to the listing license holder, and to force the listed license holder to assume the supervision and restraint role of the pharmaceutical representative's promotion behavior by means of filing.
National organization of drugs, consumables with the normal procurement, on the one hand, is an important means of medical insurance fee control, on the other hand, also through the compression of drugs, supplies price moisture, squeeze out the enterprise with gold sales space, and promote the transformation and upgrading of China's end drug market.
With more and more clinical use, high procurement amount, the use of mature products are included in the national organization centralized belt procurement, will make enterprises from homogenized products marketing competition to accelerate product research and development innovation.
As for the reform of medical insurance payment methods, whether drG or DIP, or by bed-day, pay-per-person exploration and pilot, are in the way of prepaid to promote medical institutions to save medical costs, improve service quality, and turn to value medicine.
It can be said that under the comprehensive power of a series of policies, in the Central Commission for Discipline Inspection, the Health Care Commission, the Health Insurance Bureau, the Supreme Law and other departments closely linked, relying on gold sales, rebates and other ways to ensure the clinical sales of drugs behavior, survival space will be smaller and smaller, drug promoters and pharmaceutical enterprises between the market competition will eventually turn to academic and innovative contention.
。